Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy.

Salaru DL, Albert C, Königsmark U, Brandt S, Halloul Z, Heller A, Heidecke H, Dragun D, Mertens PR.

Int Angiol. 2014 Aug;33(4):372-8.

PMID:
25056169
2.

In arterial occlusive disease autoantibodies against ETAR and AT(1)R correlate with each other but are not associated with classical cardiovascular risk factors.

Albert C, von Schultzendorff M, Şalaru D, Halloul Z, Dragun D, Heidecke H, Mertens PR.

Vasa. 2014 Mar;43(2):113-23. doi: 10.1024/0301-1526/a000337.

PMID:
24627317
3.

Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis.

López-Mejías R, Genre F, González-Juanatey C, González-Gay MA.

Vasa. 2014 Mar;43(2):83-5. doi: 10.1024/0301-1526/a000333. No abstract available.

PMID:
24627313
4.

Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels.

Ishigami T, Abe K, Aoki I, Minegishi S, Ryo A, Matsunaga S, Matsuoka K, Takeda H, Sawasaki T, Umemura S, Endo Y.

FASEB J. 2013 Sep;27(9):3437-45. doi: 10.1096/fj.12-222653. Epub 2013 May 22.

PMID:
23699176
5.

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.

Riemekasten G, Philippe A, Näther M, Slowinski T, Müller DN, Heidecke H, Matucci-Cerinic M, Czirják L, Lukitsch I, Becker M, Kill A, van Laar JM, Catar R, Luft FC, Burmester GR, Hegner B, Dragun D.

Ann Rheum Dis. 2011 Mar;70(3):530-6. doi: 10.1136/ard.2010.135772. Epub 2010 Nov 15.

PMID:
21081526
6.

Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.

Budding K, van de Graaf EA, Hoefnagel T, Kwakkel-van Erp JM, van Kessel DA, Dragun D, Hack CE, Otten HG.

J Cyst Fibros. 2015 Jan;14(1):42-5. doi: 10.1016/j.jcf.2014.07.007. Epub 2014 Aug 2.

7.

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.

Günther J, Kill A, Becker MO, Heidecke H, Rademacher J, Siegert E, Radić M, Burmester GR, Dragun D, Riemekasten G.

Arthritis Res Ther. 2014 Mar 11;16(2):R65. doi: 10.1186/ar4503.

8.

Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.

Dimitrijevic I, Edvinsson ML, Chen Q, Malmsjö M, Kimblad PO, Edvinsson L.

BMC Cardiovasc Disord. 2009 Aug 25;9:40. doi: 10.1186/1471-2261-9-40.

9.

Identification of a Novel Agonist-Like Autoantibody in Preeclamptic Patients.

Velloso EP, Pimentel RL, Braga JF, Cabral AC, Reis ZS, Bader M, Santos RA, Wallukat G.

Am J Hypertens. 2016 Mar;29(3):405-12. doi: 10.1093/ajh/hpv099. Epub 2015 Jul 8.

PMID:
26158852
10.

Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.

Jalkanen J, Yegutkin GG, Hollmén M, Aalto K, Kiviniemi T, Salomaa V, Jalkanen S, Hakovirta H.

Circ Res. 2015 Mar 27;116(7):1206-15. doi: 10.1161/CIRCRESAHA.116.305715. Epub 2015 Feb 2.

11.

[Positive rate of autoantibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension].

Zhao LS, Liao YH, Xiang GD, Wang M, Yue L, Zhou ZH, Sun HL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Feb;38(2):139-42. Chinese.

PMID:
20398560
12.

Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.

Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, Cheng X, Zhang M, Ma XL, Liu H.

J Hypertens. 2008 Aug;26(8):1629-35. doi: 10.1097/HJH.0b013e328304dbff.

PMID:
18622242
13.

Daily non-soy legume consumption reverses vascular impairment due to peripheral artery disease.

Zahradka P, Wright B, Weighell W, Blewett H, Baldwin A, O K, Guzman RP, Taylor CG.

Atherosclerosis. 2013 Oct;230(2):310-4. doi: 10.1016/j.atherosclerosis.2013.07.048. Epub 2013 Aug 6.

PMID:
24075762
14.

Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.

Agarwal AK, Singh M, Arya V, Garg U, Singh VP, Jain V.

J Assoc Physicians India. 2012 Jul;60:28-32.

PMID:
23405538
15.

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.

Hamano K, Nakadaira I, Suzuki J, Gonai M.

Vasc Health Risk Manag. 2014 Oct 3;10:585-9. doi: 10.2147/VHRM.S67753. eCollection 2014. Erratum in: Vasc Health Risk Manag. 2014;10:649.

16.

Serum midkine as a predictor of cardiac events in patients with chronic heart failure.

Kitahara T, Shishido T, Suzuki S, Katoh S, Sasaki T, Ishino M, Nitobe J, Miyamoto T, Miyashita T, Watanabe T, Takeishi Y, Kubota I.

J Card Fail. 2010 Apr;16(4):308-13. doi: 10.1016/j.cardfail.2009.12.014. Epub 2010 Feb 26.

PMID:
20350697
17.

Plasma netrin-1 levels significantly increase in smokers.

Kızmaz M, Marakoğlu K, Kıyıcı A, Ay E.

Clin Biochem. 2016 Jul;49(10-11):832-4. doi: 10.1016/j.clinbiochem.2016.02.011. Epub 2016 Mar 2.

PMID:
26944719
18.

[Expression and significance of AT1-AA and ET1 in materal peripheral blood, umbilical cord blood and placenta in preeclampsia].

Zhao XL, Liu Z, Liu C.

Zhonghua Fu Chan Ke Za Zhi. 2012 Oct;47(10):721-5. Chinese.

PMID:
23302726
19.

Role of anti-HSP 60/65 antibodies in atherogenesis in patients with type 2 diabetes and lower limb ischemia.

Rabczynski M, Fiodorenko-Dumas Z, Adamiec R, Paprocka-Borowicz M, Dumas I.

J Physiol Pharmacol. 2012 Dec;63(6):691-6.

20.

Midkine in plasma as a novel breast cancer marker.

Ibusuki M, Fujimori H, Yamamoto Y, Ota K, Ueda M, Shinriki S, Taketomi M, Sakuma S, Shinohara M, Iwase H, Ando Y.

Cancer Sci. 2009 Sep;100(9):1735-9. doi: 10.1111/j.1349-7006.2009.01233.x. Epub 2009 Jun 1.

Supplemental Content

Support Center